|
Welcome to datamethods
|
|
1
|
7749
|
July 24, 2018
|
|
Necessary/recommended level of theory for developing statistical intuition
|
|
29
|
1168
|
May 21, 2022
|
|
Comparison of diagnostic tests performance
|
|
4
|
61
|
May 21, 2022
|
|
Ordered predictors in ordinal models
|
|
2
|
44
|
May 21, 2022
|
|
Repeated exposure measures, single (cross-sectional) outcome measure
|
|
0
|
28
|
May 20, 2022
|
|
Reference Collection to push back against "Common Statistical Myths"
|
|
48
|
67276
|
May 20, 2022
|
|
Ordinal vs. Multinomial Logistic Regression?
|
|
4
|
268
|
May 20, 2022
|
|
Issues with incorporation bias in prognostic studies?
|
|
0
|
95
|
May 18, 2022
|
|
The End of the "Syndrome" in Critical Care
|
|
17
|
1550
|
May 18, 2022
|
|
Individual response
|
|
114
|
10749
|
May 17, 2022
|
|
RMS Ordinal Regression for Continuous Y
|
|
18
|
7358
|
May 15, 2022
|
|
RMS Multivariable Modeling Strategies
|
|
7
|
6012
|
May 15, 2022
|
|
Should adverse effects be adjusted for multiple comparisons?
|
|
3
|
161
|
May 14, 2022
|
|
Comparing non-nested models on the same data
|
|
4
|
206
|
May 13, 2022
|
|
Predictive modelling of crossover trial with a binary outcome and four interventions
|
|
0
|
86
|
May 12, 2022
|
|
Quality of remdesivir trials
|
|
51
|
8252
|
May 12, 2022
|
|
Correlated Dataset Generator
|
|
1
|
162
|
May 11, 2022
|
|
Discussion of Assessing Heterogeneity of Treatment Effect, Estimating Patient-Specific Efficacy, and Studying Variation in Odds ratios, Risk Ratios, and Risk Differences
|
|
9
|
3849
|
May 11, 2022
|
|
Is it the numerator or denominator which explains variations of a ratio?
|
|
1
|
165
|
May 11, 2022
|
|
Overconfident forecasts in infectious disease epidemiology
|
|
5
|
137
|
May 11, 2022
|
|
Resources for Learning Likelihood and Bayesian Methods
|
|
1
|
1057
|
May 11, 2022
|
|
How to compare 2 nonlinear curves?
|
|
5
|
240
|
May 11, 2022
|
|
Internal validation: Imputation nested within bootstrap
|
|
2
|
142
|
May 9, 2022
|
|
Clarification on risk magnification
|
|
7
|
140
|
May 9, 2022
|
|
Statistically Efficient Ways to Quantify Added Predictive Value of New Measurements
|
|
43
|
8481
|
May 9, 2022
|
|
Prospective OR Retrospective Cohort Study?
|
|
3
|
908
|
May 8, 2022
|
|
Should I impute person-time before conducting proportional hazards analysis?
|
|
7
|
129
|
May 8, 2022
|
|
Background to PFS endpoint
|
|
16
|
691
|
May 8, 2022
|
|
What are the decision rules for concluding on the effectiveness of the treatment when intermediate analyses are planned?
|
|
6
|
244
|
May 8, 2022
|
|
Summary Statistics vs Raw Data
|
|
8
|
3738
|
May 7, 2022
|